000 02397nam a2200505 i 4500
999 _c279583
_d279583
001 ocn681839503
003 OCoLC
005 20190313121449.0
006 m o d f
007 cr bn|||||||||
008 101117s2000 dcua ob f000 0 eng c
040 _aPUCPR
_beng
_erda
_epn
_cOCLCE
_dOCLCQ
_dOCLCF
_dOCLCO
_dOCLCA
_dOCLCQ
_dCWCLL
_dNJR
_dOCLCQ
_dOCL
_dOCLCA
_dUWO
_dOCLCQ
_dGPO
_dMvI
042 _apcc
043 _an-us---
074 _a1016-C (online)
086 0 _aY 4.G 74/7:F 31/86
088 _aSerial no. 106-60 (United States. Congress. House. Committee on Government Reform)
099 _aY 4.G 74/7:F 31/86
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Government Reform,
245 1 0 _aHow accurate is the FDA's monitoring of supplements like ephedra? :
_bhearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999.
246 3 _aHow accurate is the Food and Drug Administration's monitoring of supplements like ephedra?
264 1 _aWashington :
_bU.S. Government Printing Office,
_c2000.
300 _a1 online resource (iii, 214 pages) :
_billustrations
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
500 _a"Serial no. 106-60."
500 _aCRDP Program record.
504 _aIncludes bibliographical references.
588 _aDescription based on online resource; title from PDF title page (govinfo, viewed Feb. 25, 2019).
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Government Reform.
_tHow accurate is the FDA's monitoring of supplements like ephedra?
_w(DLC) 00325568
_w(OCoLC)43523640
856 4 0 _uhttps://purl.fdlp.gov/GPO/gpo116620
050 4 _aKF27
_b.G6 1999h
610 1 0 _aUnited States.
_bFood and Drug Administration
_xRules and practice.
610 1 7 _aUnited States.
_bFood and Drug Administration.
_2fast
650 0 _aDietary supplements
_xGovernment policy
_zUnited States.
650 0 _aDrugs
_xSide effects
_xGovernment policy
_zUnited States.
650 0 _aProduct safety
_zUnited States.
650 0 _aEphedra
_xTherapeutic use
_xSide effects
_zUnited States.
650 7 _aDietary supplements.
_2fast
651 7 _aUnited States.
_2fast
655 7 _aRules.
_2fast
655 7 _aLegislative hearings.
_2lcgft
942 _2sudocs
_c8